A Clue for Telangiectasis in Systemic Sclerosis: Elevated Serum Soluble Endoglin Levels in Patients with the Limited Cutaneous Form of the Disease
Authors:
- M. FujimotoMFM. Fujimoto
- M. HasegawaMHM. Hasegawa
- Y. HamaguchiYHY. Hamaguchi
- K. KomuraKKK. Komura
- T. MatsushitaTMT. Matsushita
- K. YanabaKYK. Yanaba
- M. KoderaMKM. Kodera
- K. TakeharaKTK. Takehara
- S. SatoSSS. Sato
- 1 August 2006
- journal article
- Published by S. Karger AG in Dermatology
- Vol. 213 (2) , 88-92
Abstract
Background: The transforming growth factor-β (TGF-β) system plays a critical role both in systemic sclerosis (SSc) and hereditary hemorrhagic telangiectasia (HHT). Endoglin, known as a gene responsible for HHT, is a TGF-β receptor preferentially expressed on endothelial cells. The role of endoglin in SSc is potentially intriguing since limited cutaneous SSc (lcSSc) and HHT share several symptoms, including telangiectasia. Objective: To determine serum levels of soluble endoglin (sEndoglin) and clinical associations in patients with SSc. Methods: Serum sEndoglin levels were examined by ELISA in 70 patients with SSc, 20 patients with systemic lupus erythematosus and 20 healthy individuals. Results: Serum sEndoglin levels were significantly elevated in patients with lcSSc compared with diffuse cutaneous SSc and systemic lupus erythematosus patients as well as normal controls. Patients with elevated sEndoglin levels had telangiectasia more frequently than those with normal sEndoglin levels. Furthermore, pulmonary artery pressure was positively correlated with sEndoglin levels in patients with lcSSc. Conclusion: Abnormal expression/function of endoglin may be linked to lcSSc-specific manifestations.Keywords
This publication has 11 references indexed in Scilit:
- Pulmonary Arterial Hypertension in Systemic SclerosisTreatments in Respiratory Medicine, 2004
- Predominant Telangiectatic Erythema in Linear Atrophoderma of Moulin: Novel Variant or Separate Entity?Dermatology, 2003
- Pathogenesis of fibrosis: role of TGF-β and CTGFCurrent Opinion in Rheumatology, 2002
- Dysregulation of transforming growth factor β signaling in scleroderma: Overexpression of endoglin in cutaneous scleroderma fibroblastsArthritis & Rheumatism, 2002
- Transforming growth factor-β and connective tissue growth factor: key cytokines in scleroderma pathogenesisCurrent Opinion in Rheumatology, 2001
- Clinical and Molecular Genetic Features of Pulmonary Hypertension in Patients with Hereditary Hemorrhagic TelangiectasiaNew England Journal of Medicine, 2001
- Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1Nature Genetics, 1994
- Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosisArthritis & Rheumatism, 1988
- The 1982 revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1982
- Preliminary criteria for the classification of systemic sclerosis (scleroderma)Arthritis & Rheumatism, 1980